MG
IMCC

Michael Gelband’s IM Cannabis IMCC Stock Holding History

Michael Gelband’s Portfolio IMCC Stock Details IMCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,579
Closed -$63K – 1852
2022
Q3 		$63K Buy
+2,579
New +$79.8K ﹤0.01% 1786

Other funds holding IMCC

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BMCM
Black Maple Capital Management Milwaukee, Wisconsin $176M AUM 9.49% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
ECM
EMC Capital Management Houston, Texas $253M AUM
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Michael Gelband's IMCC Position: Q4 2022 in Review

Michael Gelband sold out of IM Cannabis (IMCC) in Q4 2022, closing a stake of 2,579 shares — an estimated $63K sold.

Michael Gelband first reported a position in IMCC in Q3 2022 and held it in 1 quarter. The position peaked at $63K in Q3 2022. 18 funds tracked by Wall St. Rank hold IMCC as of Q4 2022.

  • Michael Gelband reported no remaining IM Cannabis position as of Q4 2022 after selling out during the quarter.
  • Michael Gelband sold 2,579 IM Cannabis shares in Q4 2022, an estimated $63K.
  • Michael Gelband first reported a position in IM Cannabis in Q3 2022 and held it in 1 quarter.
  • Michael Gelband's IM Cannabis position peaked at $63K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held IM Cannabis as of Q4 2022.

Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.